Navigation Links
Zargis Awarded U.S. Army Contract
Date:7/21/2010

STAMFORD, Conn., July 21 /PRNewswire-FirstCall/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that it received a contract from the U.S. Army to develop an investigational device based on the success of the Signal-X6™ telemedicine systems recently deployed to the Army under a separate contract. Under the terms of the new contract, Zargis will develop prototype versions of the Signal-X6 system that will incorporate automated heart sound detection and murmur classification functionality similar to that offered by the award-winning Zargis Cardioscan software.  This $120,000 contract will commence on August 1st, 2010.

Due to the fact that each Signal-X6 device incorporates six acoustic sensors that simultaneously record sounds from a patient's torso, this new project will allow Zargis to enhance its proprietary heart sounds analysis technology by leveraging multi-channel heart sound input instead of relying on input from the single sensor contained in a stethoscope.

"We are excited about this latest chapter in our ongoing relationship with the U.S. Army," stated Zargis CEO John Kallassy. "As our Signal-X6 systems continue to be evaluated throughout the Army's Military Treatment Facilities, we anticipate that the integration of our heart sounds analysis algorithms will lead the Army, and others, to deploy our devices on a wider scale."

Zargis expects that clinical data obtained regarding this project will culminate in the development of an Army-sponsored research paper.

The development of the investigational device described in the contract is being funded by the Telemedicine and Advanced Technology Research Center (TATRC) through the AAMTI program. The AAMTI program provides funding to AMEDD personnel to demonstrate technology and document the impact on cost, access and quality of care. TATRC (www.tatrc.org) is an element of the United States Army Medical Research and Materiel Command (USAMRMC).

About Zargis Medical Corp.

Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through diagnostic support software and innovation. Zargis is majority-owned by Speedus Corp. (Nasdaq: SPDE), and both 3M Company and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), hold equity positions.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or phodge@zargis.com, or visit the following Web sites: www.zargis.com and www.speedus.com.

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.


'/>"/>
SOURCE Speedus Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
2. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
3. Zargis Cardioscan Cleared for Sale in Canada
4. Zargis Cardioscan(TM) Featured on The Early Show on CBS
5. Zargis Cardioscan The Intelligent Stethoscope Now Available on Amazon.com
6. Zargis Cardioscan Jointly Named as Finalist in 2010 Edison Best New Product Awards
7. Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia
8. Zargis Medical Strikes Gold at 2010 Edison Awards
9. Zargis Launches Telemedicine System with Real-Time Transmission of Stethoscope Sounds
10. Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc.
11. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... According to a new market research report "Sunitinib Malate ... Germany , France , U.K., ... Japan )", published by MarketsandMarkets, The market is projected to ... from 2016 to 2021.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302 ... through 26 Pages and in-depth TOC on "Sunitinib Malate ...
(Date:5/19/2016)... AVIV, Israel , May 19, 2016 ... or the "Company"), an emerging global ophthalmic company focused ... product candidates which address ophthalmic conditions, announced today that ... Italy ) for the manufacturing, distribution, ... product for the treatment of dry eye syndrome (DES) ...
(Date:5/19/2016)... May 19, 2016 At the 18 ... Meeting in Amsterdam , (May 15-19), Elekta ... clinically-proven radiosurgery system available, has been used in the ... brain tumors, vascular malformations and functional disorders. ... 75,000 patients every year in hundreds of leading hospitals ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... research and education, today announced that it has named Scott Santarella as its ... J. Addario Lung Cancer Foundation (ALCF) in San Francisco, where he successfully helped ...
(Date:5/24/2016)... ... ... After graduating from Cornell, author Joshua Alexander was diagnosed with ... on Social Security disability and staying in a group home. In “ Healing Schizoaffective ... Balboa Press), Alexander shares how he was finally able to heal with the help ...
(Date:5/24/2016)... ... 2016 , ... PhysicianOne Urgent Care, advocators in helping their patients lead the ... avoid being bitten this spring. , The official tick season kicks off in ... are known for attaching themselves to their prey while they feed off their blood. ...
(Date:5/24/2016)... Lafayette, Colorado (PRWEB) , ... May 24, 2016 ... ... landscape architecture firm, announces the grand opening of ‘El Centro del Quinto Sol ... citizens of the Pueblo ‘east side’ community to offer something special for this ...
(Date:5/24/2016)... CA (PRWEB) , ... May 24, 2016 , ... ... cell imaging; high content imaging; multiplex immunoassays are widely used for cell and ... for labs to maximize their quality and efficiency in these areas. , LabRoots ...
Breaking Medicine News(10 mins):